BIOMAT Database Logo BIOMAT Database Logo

Trade names or approved names. Part III. Special cases. The digoxin affair. 1974

T R Shaw

UI MeSH Term Description Entries
D009626 Terminology as Topic Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area. Etymology,Nomenclature as Topic,Etymologies
D011307 Drug Prescriptions Directions written for the obtaining and use of DRUGS. Drug Prescribing,Drug Prescription,Drug Prescribings,Prescribing, Drug,Prescribings, Drug
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004363 Drug Utilization The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. Utilization, Drug,Drug Utilizations,Utilizations, Drug
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic

Related Publications

T R Shaw
Trade names or approved names. Part III. Special cases. Antibiotics.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part III. Special cases. Combination products.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part III. Special cases. Clinical trials.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part III. Special cases. Anti-diabetic drugs.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part III. Special cases. Anti-rheumatic drugs.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part III. Special cases. Drugs for rare diseases.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part IV. The solution. Introduction.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part 1. The situation Substitution: right or wrong?
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part II. Points of view. Europe.
February 1974, Postgraduate medical journal,
T R Shaw
Trade names or approved names. Part II. Points of view. The nurse.
February 1974, Postgraduate medical journal,
Copied contents to your clipboard!